SCHEMBL9704527

SCHEMBL9704527

CCc1cc(-c2ccccc2)nc(-c2ccccc2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.51
MEN1 O00255 8/20 0.50
KMT2A Q03164 8/20 0.50
RAB9A P51151 4/20 0.50
MAPT P10636 5/20 0.48
TDP1 Q9NUW8 2/20 0.48
TSHR P16473 1/20 0.48
ATM Q13315 1/20 0.48
ADORA2A P29274 4/20 0.48
ADORA1 P30542 4/20 0.48
ALDH1A1 P00352 4/20 0.48
HPGD P15428 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
TP53 P04637 1/20 0.48
ADORA3 P0DMS8 2/20 0.47
NTSR1 P30989 1/20 0.47
NPC1 O15118 2/20 0.46
ADORA2B P29275 1/20 0.46
MAPK1 P28482 1/20 0.46
KDM4E B2RXH2 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22333776 0.86 CYP19A1 (0.65) SMN1; SMN2RAB9AMAPTADORA2AALDH1A1
SCHEMBL4496702 0.84 MEN1 (0.51) SMN1; SMN2MEN1KMT2ARAB9AMAPT
SCHEMBL12055792 0.83 BCL2 (0.50) SMN1; SMN2MEN1KMT2ARAB9AMAPT
SCHEMBL12551317 0.82 MEN1 (0.54) SMN1; SMN2MEN1KMT2ARAB9AMAPT
SCHEMBL23184057 0.80 MEN1 (0.59) SMN1; SMN2MEN1KMT2ARAB9AMAPT
SCHEMBL9705061 0.80 DHODH (0.52) MEN1KMT2ARAB9AMAPTTSHR
SCHEMBL18388725 0.80 MEN1 (0.59) SMN1; SMN2MEN1KMT2ARAB9AMAPT
SCHEMBL19383729 0.79 MEN1 (0.54) SMN1; SMN2MEN1KMT2AMAPTTDP1
SCHEMBL597228 0.79 TP53 (0.60) SMN1; SMN2RAB9AMAPTALDH1A1L3MBTL1
SCHEMBL12939255 0.78 MEN1 (0.54) SMN1; SMN2MEN1KMT2ARAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0463492-A1 2,6-Diarylpyridin derivatives BAYER AG (DE) 1992-01-02 EP claimed
US-20210328154-A1 PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2021-10-21 US disclosed
EP-3664172-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DIODE, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE Samsung SDI Co., Ltd. (KR) 2020-06-10 EP disclosed
EP-3486299-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE Samsung SDI Co., Ltd. (KR) 2019-05-22 EP disclosed
US-10032990-B2 Organic composition, and organic optoelectronic element and display device SAMSUNG SDI CO., LTD. (KR) 2018-07-24 US disclosed
EP-2818462-B1 CYCLIC AZINE DERIVATIVES, PROCESSES FOR PRODUCING THESE, AND ORGANIC ELECTROLUMISCENT ELEMENT CONTAINING THESE AS COMPONENT TOSOH CORP (JP) 2017-11-08 EP disclosed
US-20170149007-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-05-25 US disclosed
US-20170077410-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND USE THEREOF LUMINESCENCE TECHNOLOGY CORP. (TW) 2017-03-16 US disclosed
US-20160372679-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENCE DEVICE LUMINESCENCE TECHNOLOGY CORP. (TW) 2016-12-22 US disclosed
US-8643268-B2 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2014-02-04 US disclosed
US-20120248968-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. 2012-10-04 US disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
EP-0463492-A1 2,6-Diarylpyridin derivatives BAYER AG (DE) 1992-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10032990-B2 Organic composition, and organic optoelectronic element and display device OCIAD2, OCIAD1, OR51E2 SMN1; SMN2 3287/4885MEN1 2329/4885KMT2A 3582/4885
US-20160372679-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENCE DEVICE CCNE2, CYP3A4, CCNE1 SMN1; SMN2 1753/4885MEN1 1572/4885KMT2A 2018/4885
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A SMN1; SMN2 3636/4885MEN1 3994/4885KMT2A 2323/4885
US-20170149007-A1 ORGANIC ELECTROLUMINESCENCE DEVICE EML4, EHD1, OR10J3 SMN1; SMN2 2398/4885MEN1 1892/4885KMT2A 2849/4885
US-20170077410-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND USE THEREOF HBS1L, EML4, EBPL SMN1; SMN2 4275/4885MEN1 2079/4885KMT2A 2295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.